Mid- or High-flex Rods Versus Low-flex Rods of SpineShape System IV for Treatment of Degenerative Lumbar Spine Diseases
NCT ID: NCT06320899
Last Updated: 2024-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
126 participants
INTERVENTIONAL
2024-06-04
2031-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary aim is to compare the reduction in back pain after the treatment with high- or mid-flex rods with that after treatment with low-flex rods. Secondary, the functionality after treatment with high- or mid-flex rods will be compared to that after treatment with low-flex rods.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Treatment of Spinal Deformity With Sagittal Imbalance Using Patient-specific Rods: A Multicenter, Controlled, Double- Blind Randomized Trial: The PROFILE Study
NCT02730507
Assessing Superion Clinical Endpoints vs. Decompression
NCT03048955
Epidural Steroid Injection Versus Epidural Steroid Injection and Manual Physical Therapy and Exercise in the Management of Lumbar Spinal Stenosis
NCT00786981
Minuteman Spinal Fusion Implant Versus Surgical Decompression for Lumbar Spinal Stenosis
NCT01455805
Indirect vs. Direct Decompression for Treatment of Central Stenosis: RCT
NCT04708977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the study is to show that the treatment of degenerative lumbar spine with elastic or medium rod variants is not inferior to treatment with hard rods in terms of clinical and safety-related results. This is checked by completing a questionnaire before the surgical procedure and 3 months, 12 months, 24 months and 60 months after the surgical procedure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SpineShape System IV straight rod elastic
Dynamic stabilization of lumbar segments using SpineShape System IV straight rod elastic (high-flex)
SpineShape System IV straight rod elastic
Implantation of SpineShape System IV straight rod elastic
SpineShape System IV straight rod medium
Dynamic stabilization of lumbar segments using SpineShape System IV straight rod medium (mid-flex)
SpineShape System IV straight rod medium
Implantation of SpineShape System IV straight rod medium (mid-flex)
SpineShape System IV straight rod stiff
Dynamic stabilization of lumbar segments using SpineShape System IV straight rod stiff (low-flex)
SpineShape System IV straight rod stiff
Implantation of SpineShape System IV straight rod stiff (low-flex)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SpineShape System IV straight rod elastic
Implantation of SpineShape System IV straight rod elastic
SpineShape System IV straight rod medium
Implantation of SpineShape System IV straight rod medium (mid-flex)
SpineShape System IV straight rod stiff
Implantation of SpineShape System IV straight rod stiff (low-flex)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* signed informed consent of participant
* confirmation of the participant that the attendance of follow-up visits are intended
* Body-Mass-Index \< 32
* Pedicle screw axis distance \< 30mm
* one or more of the following indications:
* (dynamic) stenosis in the spinal canal
* neuroforaminal stenosis
* facet joint syndrome / spondylarthrosis
* discopathy (recurrent disc hernia)
* degenerative spondylolisthesis (Meyerding \<1)
* instability (hypermobility with antelishtesis, hypomobility with retrolisthesis if decompressed)
Exclusion Criteria
* damaged structural tissue, e.g. due to a bone fracture
* application to the thoracic or cervical spine
* pronounced idiopathic scoliosis
* spondylolisthesis \> Meyerding grad 1
* isthmic spondolylysis
* bone tumor
* osteochondrosis modic type I, II or III
* osteoporosis, which could impair screw anchoring
* history with third party implants
* patients with an active local or systemic infection
* known allergy to titatnium alloys
* skeleton in growth (epiphyseal joints not closed)
* severe muscular neuronal or vascular disease
* immunosuppresive therapy
* long-term therapy with cortisone
* heavy smokers (regular consumption of more than six cigarettes per day), drug addicts and alcoholics
* chronic pain patients
* incapable of judgment or emergency situation
* implantation during pregnancy
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SpineSave AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philipp Cathrein, Dr.med.
Role: PRINCIPAL_INVESTIGATOR
Hirslanden Klinik Linde
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spital Aarberg
Aarberg, , Switzerland
Hirslanden Klinik Linde
Biel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BASEC 2023-D0092
Identifier Type: OTHER
Identifier Source: secondary_id
SpineShape_CH_001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.